0 Drug-resistant Candida auris spreading in UK hospitals
Public Health England has released updated guidance on Candida auris, as they confirm that over 200 patients have been infected or colonized with the fungus.
Browsing: Clinical > Clinical Diseases
0 Invasive Aspergillosis in the Intensive Care Unit
In this feature, ID Hub discusses the risk factors contributing to invasive Aspergillosis susceptibility, in addition to the obstacles facing diagnosis and therapy in the Intensive Care Unit.
0 Are cases of recurrent Clostridium difficile infection on the rise in the United States?
An analysis of a large, nationwide health insurance database reveals a rapid increase in multiple recurring Clostridium difficile infections in the United States.
0 How can ventilator-associated pneumonia be prevented in hospitals?
Researchers demonstrate how one of the deadliest hospital-acquired infections can be prevented by training and culture-change interventions.
0 Could chitosan-containing hydrogel wound dressings reduce the risk of infection?
A novel type of wound dressing that combines both hydrogel dressings and chitosan could reduce the risk of bacterial infection in recovering patients.
0 Molecular antibiogram in diagnostic clinical microbiology: advantages and challenges
In this editorial the authors offer a perspective about issues surrounding the implementation of molecular antibiograms in the diagnostic workflow.
0 ECCMID17: New test could detect colistin resistance in bacteria
New research suggests it may be possible to quickly and accurately diagnose drug-resistant bacteria utilizing equipment already owned by hospitals.
0 ECCMID17: DNA fingerprinting suggests food may be a source of C. difficile
In research presented at ECCMID 2017, scientists have suggested foods should be investigated as potential source of C. difficile.
0 Inhibition of MRSA and of Clostridium difficile by durancin 61A: synergy with bacteriocins and antibiotics
This study delves aims to evaluate the efficacy of durancin 61A as an inhibitor of resistant clinical pathogens and to shed light on its mode of action.
0 Acyldepsipeptide antibiotics as a potential therapeutic agent against Clostridium difficile recurrent infections
This perspective discusses the urgent need for novel and efficient antimicrobial strategies against C. difficile and the authors evaluate the application of the acyldepsipeptides family of antibiotics to treat C. difficile infections.